Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age.
Leukemia
View this publicationLeukemia
View this publicationJournal of mathematical imaging and vision
View this publicationTrials
View this publicationCritical care (London, England)
View this publicationEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
View this publicationMicroorganisms
View this publicationVASA. Zeitschrift fur Gefasskrankheiten
View this publicationNature reviews. Urology
View this publicationBritish journal of pharmacology
View this publicationVirology journal
View this publication